S100A8 and cancer: However, limited studies have focused on the significance of S100A8 and TME in cancer based on the current excellent design approach, and we aimed to use bioinformatics to explore SAS100A8 expression in 33 different malignant tumors and its potential effect on immune TME [11, 12].